L G Czaplewski - JoVE Visualize

Showing results (1-10 of 12) with videos related to

Pageof 2

Sort By:

Journal of Hematotherapy & Stem Cell Research|November 25, 2000

Identification and characterization of a rat macrophage inflammatory protein-1alpha receptorA Waller, P Nayee, L G Czaplewski

The Journal of Biological Chemistry|September 17, 1999

Aggregation of RANTES is responsible for its inflammatory properties. Characterization of nonaggregating, noninflammatory RANTES mutantsV Appay, A Brown, S Cribbes, et al.

Leukemia & Lymphoma|July 21, 1998

The growth inhibitory role and potential clinical value of macrophage inflammatory protein 1 alpha in myeloid leukaemiasP J Owen-Lynch, L G Czaplewski, M G Hunter, et al.

Journal of Molecular Biology|May 20, 1990

Crystallization of the arginine-dependent repressor/activator AhrC from Bacillus subtilisC W Boys, L G Czaplewski, S E Phillips, et al.

Molecular Microbiology|January 1, 1992

Purification and initial characterization of AhrC: the regulator of arginine metabolism genes in Bacillus subtilisL G Czaplewski, A K North, M C Smith, et al.

Cytokines, Cellular & Molecular Therapy|March 1, 1997

The effects of human macrophage inflammatory protein-1 alpha and its genetically modified variant, BB10010, on phagocyte functionS L Williams, I E Addison, E Mollapour, et al.

British Journal of Haematology|October 1, 1996

The effect of the chemokine rhMIP-1 alpha, and a non-aggregating variant BB-10010, on blast cells from patients with acute myeloid leukaemiaP J Owen-Lynch, J A Adams, M L Brereton, et al.

Blood|June 15, 1995

Mobilization of early hematopoietic progenitor cells with BB-10010: a genetically engineered variant of human macrophage inflammatory protein-1 alphaB I Lord, L B Woolford, L M Wood, et al.

Protein Science : a Publication of the Protein Society|December 6, 2000

Chemical modification of a variant of human MIP-1alpha; implications for dimer structureJ T Ashfield, T Meyers, D Lowne, et al.

Blood|December 15, 1995

BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical propertiesM G Hunter, L Bawden, D Brotherton, et al.

Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:

Pageof 2

Journal of Hematotherapy & Stem Cell Research|November 25, 2000

Identification and characterization of a rat macrophage inflammatory protein-1alpha receptorA Waller, P Nayee, L G Czaplewski

The Journal of Biological Chemistry|September 17, 1999

Aggregation of RANTES is responsible for its inflammatory properties. Characterization of nonaggregating, noninflammatory RANTES mutantsV Appay, A Brown, S Cribbes, et al.

Leukemia & Lymphoma|July 21, 1998

The growth inhibitory role and potential clinical value of macrophage inflammatory protein 1 alpha in myeloid leukaemiasP J Owen-Lynch, L G Czaplewski, M G Hunter, et al.

Journal of Molecular Biology|May 20, 1990

Crystallization of the arginine-dependent repressor/activator AhrC from Bacillus subtilisC W Boys, L G Czaplewski, S E Phillips, et al.

Molecular Microbiology|January 1, 1992

Purification and initial characterization of AhrC: the regulator of arginine metabolism genes in Bacillus subtilisL G Czaplewski, A K North, M C Smith, et al.

Cytokines, Cellular & Molecular Therapy|March 1, 1997

The effects of human macrophage inflammatory protein-1 alpha and its genetically modified variant, BB10010, on phagocyte functionS L Williams, I E Addison, E Mollapour, et al.

British Journal of Haematology|October 1, 1996

The effect of the chemokine rhMIP-1 alpha, and a non-aggregating variant BB-10010, on blast cells from patients with acute myeloid leukaemiaP J Owen-Lynch, J A Adams, M L Brereton, et al.

Blood|June 15, 1995

Mobilization of early hematopoietic progenitor cells with BB-10010: a genetically engineered variant of human macrophage inflammatory protein-1 alphaB I Lord, L B Woolford, L M Wood, et al.

Protein Science : a Publication of the Protein Society|December 6, 2000

Chemical modification of a variant of human MIP-1alpha; implications for dimer structureJ T Ashfield, T Meyers, D Lowne, et al.

Blood|December 15, 1995

BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical propertiesM G Hunter, L Bawden, D Brotherton, et al.

Pageof 2